PL EN


Preferences help
enabled [disable] Abstract
Number of results
Journal
2014 | 10 | 1 |
Article title

Carotid ultrasound for pulmonary arteriovenous malformation screening

Content
Title variants
Languages of publication
EN
Abstracts
EN
Objective: In patients with hereditary hemorrhagic
telangiectasia (HHT), pulmonary arteriovenous
malformations (PAVMs) can cause serious neurological
complications. Our aim was to evaluate the potential of
contrast-enhanced Doppler ultrasound (CE-US) of the
common carotid artery as a screening test for detection
of PAVMs. Methods: A total of 124 consecutive patients
with HHT or a positive family history underwent screening
for PAVMs with CE-US and thoracic contrast-enhanced
magnetic resonance angiography (CE-MRA). CE-US was
performed after receiving (D)-galactose microparticulate,
and CE-MRA with gadobenate dimeglumine. Twenty-five
patients with confirmed PAVMs were referred to conventional
pulmonary catheter angiography (PA). Findings
on CE-US and CE-MRA were evaluated using contingency
tables and McNemar’s test. Results: Using CE-MRA as the
reference test, CE-US had a sensitivity of 100%, a specificity
of 87%, and a negative predictive value of 100%.
In 25 patients who underwent PA, PAVMs that had been
diagnosed on CE-US and CE-MRA were confirmed. Of the
PAVMs detected by CE-MRA, 24% were not identified on
PA. Conclusion: CE-US is a simple, minimally invasive
screening method that can easily be performed in different settings. CE-US can predict PAVMs with high probability
of success. CE-US may be a simple alternative to transthoracic
echocardiography in the assessment of PAVMs in
certain HHT-patients.
Publisher
Journal
Year
Volume
10
Issue
1
Physical description
Dates
online
11 - 5 - 2015
received
19 - 12 - 2014
accepted
4 - 4 - 2015
References
  • [1] Faughnan M.E., Palda V.A., Garcia-Tsao G., Geisthoff U.W.,McDonald J, Proctor D.D., et al., International guidelines forthe diagnosis and the management of hereditary hemorrhagictelangiectasia, J. Med. Genet., 2011, 48, 73-87
  • [2] Gossage J.R., Kanj G., Pulmonary arteriovenous malformations:a state of the art review, Am. J. Respir. Crit. Care Med. 1998,158, 643-661
  • [3] White R.I., Pollak J.S., Wirth J.A., Pulmonary arteriovenousmalformations: diagnosis and transcatheter embolotherapy, J.Vasc. Interv. Radiol., 1996, 7, 787-804[Crossref]
  • [4] Iqbal M., Rossoff L.J., Steinberg H.N., Marzouk K.A., SiegelD.N., Pulmonary arteriovenous malformations: a clinical review,Postgrad. Med. J., 2000, 76, 390-394
  • [5] Pollak J.S., Saluja S., Thabet A., Henderson K.J., Denbow N.,White R.I., Clinical and anatomical outcomes of pulmonary AVMEmbolotherapy, J. Vasc. Interv. Radiol., 2006, 17, 35-45
  • [6] Begbie M.E., Wallace G.M.F., Shovlin C.L., Hereditaryhaemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): aview from the 21st century, Postgrad. Med. J., 2003, 79, 18-24
  • [7] Shovlin C.L., Winstock A.R., Peters A.M., Jackson J.E., HughesJ.M., Medical complications of pregnancy in hereditaryhaemorrhagic telangiectasia. QJM, 1995, 88, 879-887
  • [8] Gershon A.S., Faughnan M.E., Chon K.S., Pugash R.A., ClarkJ.A., Bohan M.J., Henderson K.J., et al., Transcatheter embolotherapyof maternal pulmonary arteriovenous malformationsduring pregnancy, Chest, 2001, 119, 470-477
  • [9] Moussouttas M., Fayad P., Rosenblatt M., Hashimoto M., PollakJ., Henderson K., et al., Pulmonary arteriovenous malformations:Cerebral ischemia and neurological manifestations,Neurology, 2000, 55, 959-964
  • [10] Shovlin C.L., Jackson J.E., Bamford K.B., Jenkins I.H., BenjaminA.R., Ramadan H., et al., Primary determinants of ischaemicstroke/brain abscess risks are independent of severityof pulmonary arteriovenous malformations in hereditaryhaemorrhagic telangiectasia, Thorax, 2008, 63, 259-266[WoS]
  • [11] Nanthakumar K., Graham A.T., Robinson T.I., Grande P., PugashR.A., Clarke J.A., et al., Contrast echocardiography for detectionof pulmonary arteriovenous malformations, Am. Heart J., 2001,141, 243-246
  • [12] Cottin V., Plauchu H., Bayle J.-Y., Barthelet M., Revel D., CordierJ.-F., Pulmonary arteriovenous malformations in patients withhereditary hemorrhagic telangiectasia, Am. J. Respir. Crit. CareMed., 2004, 169, 994-1000
  • [13] Kjeldsen A.D., Oxhoj H., Andersen P.E., Elle B., Jacobsen J.P.,Vase P., Pulmonary arteriovenous malformations: screeningprocedures and pulmonary angiography in patients withhereditary hemorrhagic telangiectasia, Chest, 1999, 116,432-439
  • [14] van Gent M.W., Post M.C., Luermans J.G., Snijder R.J.,Westermann C.J., Plokker H.W. , et al., Screening for pulmonaryarteriovenous malformations using transthoracic contrastechocardiography: a prospective study, Eur. Resp. J., 2009, 33,85-91[WoS]
  • [15] Daniëls C., Weytjens C., Cosyns B., Schoors D., De Sutter J.,Paelinck B., et al., Second harmonic transthoracic echocardiography:the new reference screening method for the detectionof patent foramen ovale, Eur. J. Echocardiogr., 2004, 5, 449-452[Crossref]
  • [16] Thompson R.D., Jackson J., Peters M., Dore C.J., Hughes J.M.,Sensitivity and specificity of radioisotope right-left shuntmeasurements and pulse oximetry for the early detection ofpulmonary arteriovenous malformation, Chest, 1999, 115,109-113
  • [17] Shovlin C.L., Guttmacher A.E., Buscarini E., Faughnan M.E.,Hyland R.H., Westermann C.J., et al., Diagnostic criteria forhereditary hemorrhagic telangiectasia (Rendu-Osler-Webersyndrome), Am. J. Med. Genet., 2000, 91, 66-67
  • [18] Shovlin C.L., Letarte M., Hereditary haemorrhagictelangiectasia and pulmonary arteriovenous malformations:issues in clinical management and review of pathogenicmechanisms, Thorax, 1999, 54, 714-729
  • [19] Droste D.W., Lakemeier S., Wichter T., Stypmann J., DittrichR., Ritter M., et al., Optimizing the technique of contrasttranscranial Doppler ultrasound in the detection of right-to-leftshunts, Stroke 2002, 33, 221-226
  • [20] Cosgrove D., Eckersley R., Contrast-enhanced ultrasound: basicphysics and technology overview. In Enhancing the Role ofUltrasound with Contrast Agents, pp 3-14. Ed Lencioni R., 1sted., Springer, Milan, 2006.
  • [21] Soliman O.I., Geleijnse M.L., Meijboom F.J., Nemes A., KampO., Nihoyannopoulous P., Masani N., et al, The use of contrastechocardiography for the detection of cardiac shunts, Eur. J.Echocardiogr. 2007, 8, S2-12[WoS]
  • [22] Freeman J.A., Woods T.D., Use of saline contrast echo timing todistinguish intracardiac and extracardiac shunts: failure of the3- to 5-beat rule, Echocardiography, 2008, 25, 1127-1130[WoS]
  • [23] Kervancioglu S., Davutoglu V., Ozkur A., Soydinc S., AdaletliI., Sirikci A., et al.; Duplex sonography of the carotid arteriesin patients with pure aortic regurgitation: pulse waveform andhemodynamic changes and a new indicator of the severity ofaortic regurgitation, Acta Radiol:, 2004, 45, 411-416
  • [24] Draganski B., Blersch W., Holmer S., Koch H., May A., BogdahnU., et al., Detection of Cardiac Right-to-Left Shunts by Contrast-Enhanced Harmonic Carotid Duplex Sonography, J. UltrasoundMed. 2005, 24, 1071-1076[Crossref]
  • [25] Pilcher J., Blomley M., Shovlin C., Eckersley J.A.R., HamiltonG,. Harvey C., et al., Detection and quantification of pulmonaryarteriovenous shunts using an ultrasound contrast agent,presented at the 4th HHT Scientific Conference, April 2001,Tenerife, Canary Islands
  • [26] Euler U.S., Liljestrand G., Observations on the pulmonaryarterial blood pressure in the cat, Acta Physiol. Scand., 1946,12, 301-320[Crossref]
  • [27] Schneider G., Uder M., Koehler M., Massmann A., KirchinM.A., Bücker A., et al., Contrast enhanced MR angiographyfor detection of pulmonary arterio-venous malformations inpatients with hereditary hemorrhagic telangiectasia (HHT), AJR,2008, 190, 892-901
  • [28] Gazzaniga P., Buscarini E., Leandro G., Reduzzi L., Grosso M.,Pongiglione G., et al. Contrast echocardiography for pulmonaryarteriovenous malformations screening: does any bubblematter?, Eur. J. Echocardiogr., 2009, 10, 513-518[Crossref][WoS]
  • [29] Velthuis S., Buscarini E., Gossage J.R., Snijder R.J., Mager J.J.,Post M.C., Clinical Implications of Pulmonary Shunting onSaline Contrast Echocardiography, J. Am. Soc. Echocardiogr.,2015, 28, 255-263[WoS]
  • [30] Van Gent M.W.F., Post M.C., Snijder R.J., Swaans M.J., PlokkerH.W.M., Westermann C.J.J., et al., Grading of pulmonary rightto-left shunt with transthoracic contrast echocardiography,Chest, 2009, 135, 1288-1292
  • [31] Lee W.L., Graham A.F., Pugash R.A., Hutchison S.J., Grande P.,Hyland R.H., et al., Contrast echocardiography remains positiveafter treatment of pulmonary arteriovenous malformations,Chest, 2003, 123, 351-358
  • [32] Woods T.D., Harmann L., Purath T., Ramamurthy S.,Subramanian S., Jackson S., et al., Small – and moderate-sizeright-to-left shunts identified by saline contrast echocardiographyare normal and unrelated to migraine headache,Chest, 2010, 138, 264-269[WoS]
  • [33] Vase P., Holm M., Arendrup H., Pulmonary arteriovenousfistulas in hereditary hemorrhagic telangiectasia. Acta Med.Scand. 1985, 218, 105-109
  • [34] Marriott K., Manins V., Forshaw A., Wright J., Pascoe R.,Detection of right-to-left atrial communication using agitatedsaline contrast imaging: experience with 1162 patientsand recommendations for echocardiography, J. Am. Soc.Echocardiogr., 2013, 26, 96-102[WoS]
  • [35] Blackshear W.M., Phillips D.J., Chikos P.M., Harley J.D., ThieleB.L., Strandness D.E. Jr, Carotid Artery Velocity Patterns inNormal and Stenotic Vessels, Stroke, 1980, 11, 67-71[Crossref]
  • [36] Glišić T.M., Perišić M.D., Dimitrijevic S., Jurišić V., Dopplerassessment of splanchnic arterial flow in patients with livercirrhosis: correlation with ammonia plasma levels and MELDscore, J. Clin. Ultrasound, 2014, 42, 264-269[WoS]
Document Type
Publication order reference
YADDA identifier
bwmeta1.element.-psjd-doi-10_1515_med-2015-0040
Identifiers
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.